RELAPSED CLASSIC HODGKIN LYMPHOMA

Clinical trials for RELAPSED CLASSIC HODGKIN LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new RELAPSED CLASSIC HODGKIN LYMPHOMA trials appear

Sign up with your email to follow new studies for RELAPSED CLASSIC HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo aims to fight tough lymphoma, spare patients harsh transplant

Disease control Recruiting now

This study is testing whether two drugs, brentuximab vedotin and nivolumab, can effectively control classical Hodgkin lymphoma that has returned or not responded to initial treatment. The goal is to see if this combination can keep the cancer in check long-term, potentially allow…

Matched conditions: RELAPSED CLASSIC HODGKIN LYMPHOMA

Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Mar 16, 2026 15:27 UTC

RELAPSED CLASSIC HODGKIN LYMPHOMA

Get alerted when new RELAPSED CLASSIC HODGKIN LYMPHOMA trials appear

New combo aims to fight tough lymphoma, spare patients harsh transplant